These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
156 related items for PubMed ID: 2787750
1. The excretion of ketorolac tromethamine into breast milk after multiple oral dosing. Wischnik A, Manth SM, Lloyd J, Bullingham R, Thompson JS. Eur J Clin Pharmacol; 1989; 36(5):521-4. PubMed ID: 2787750 [Abstract] [Full Text] [Related]
2. Pharmacokinetics of ketorolac tromethamine in humans after intravenous, intramuscular and oral administration. Jung D, Mroszczak E, Bynum L. Eur J Clin Pharmacol; 1988; 35(4):423-5. PubMed ID: 3264245 [Abstract] [Full Text] [Related]
3. Ketorolac tromethamine. Med Lett Drugs Ther; 1990 Aug 24; 32(825):79-81. PubMed ID: 2199809 [No Abstract] [Full Text] [Related]
4. Pharmacokinetics of ketorolac and p-hydroxyketorolac following oral and intramuscular administration of ketorolac tromethamine. Jung D, Mroszczak EJ, Wu A, Ling TL, Sevelius H, Bynum L. Pharm Res; 1989 Jan 24; 6(1):62-5. PubMed ID: 2717521 [Abstract] [Full Text] [Related]
5. Clinical pharmacokinetics of ketorolac tromethamine. Brocks DR, Jamali F. Clin Pharmacokinet; 1992 Dec 24; 23(6):415-27. PubMed ID: 1458761 [Abstract] [Full Text] [Related]
13. A double-blind study with placebo control of intramuscular ketorolac tromethamine in the treatment of cancer pain. Staquet MJ. J Clin Pharmacol; 1989 Nov 24; 29(11):1031-6. PubMed ID: 2689472 [Abstract] [Full Text] [Related]
14. Transdermal delivery of ketorolac tromethamine: permeation enhancement, device design, and pharmacokinetics in healthy humans. Roy SD, Manoukian E. J Pharm Sci; 1995 Oct 24; 84(10):1190-6. PubMed ID: 8801333 [Abstract] [Full Text] [Related]